SARS-CoV-2 post-vaccine surveillance studies in Australian adults with cancer

Project: Research

Project Details

Project Description

A study adapted from a master protocol from the National Camcer Institute (USA), to inform Australian and International policy on COVID-19 vaccination in patients with cancer. SerOzNET will combine a translational arm (assessing serological and lymphocytic vaccine responses) and toxicity/quality of life measurements amongst various cohorts of participants with cancer.
Short titleSerOzNET
AcronymSerOzNET
StatusActive
Effective start/end date1/07/2130/06/22

Keywords

  • COVID-19
  • Vaccinations
  • Immunization